depression

View All

Sleep Aids Market
Sleep Aids Market: Examining Cutting-Edge Technologies and Major Breakthroughs

Sleep Aids Market: Examining Cutting-Edge Technologies and Scientific Breakthroughs Sleep can be burdensome when it disrupts daily routines, requires a significant time commitment, and is marred by sleep disorders or disturbances that affect overall well-being. In today's fast-paced world, where stress, anxiety,...

Find More

Pharma News for Pfizer, Daiichi Sankyo, Kyverna, Servier
Daiichi Sankyo’s Intravenous Iron Replacement Therapy; ANeuroTech’s Adjunctive Anti-depression Drug, ANT-01; Kyverna Therapeutics’s KYV-101 in Lupus Nephritis; Servier Presents Data from Phase 3 INDIGO Trial of Vorasidenib; FDA Approves Pfizer’s ABRYSVO

FDA Approves ABRYSVO™, Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults Pfizer Inc. announced that the FDA has authorized ABRYSVO (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of lower respiratory...

Find More

Artificial Intelligence (AI) in Mental Health
How is Artificial Intelligence (AI) Playing a Constructive Role in Mental Health Management?

As per the latest findings, the prevalence of Mental Health has grown significantly over the past two-three decades. The growth has been registered in almost every country worldwide. People of any age, race, religion or economic status can get mental illnesses. It can severely impact personal and professional life ...

Find More

Generalized Anxiety Disorder
Psychedelic-inspired medicine – A wonder drug for generalized anxiety?

In the current scenario, with an unabating urge to maintain good mental health, individuals seem quite aware of sanity and are much more likely to talk about it openly. More people are accessing care, which in turn, accounts for a notable rise in the number of cases. However, what is really steering this increase s...

Find More

major-depressive-disorder-treatment-outlook
Will a Robust Pipeline Address the Major Depressive Disorder Treatment Conundrum?

In the contemporary world, major depressive disorder (MDD) is one of the diseases responsible for the greatest healthcare burden. In the United States, more than 24 million people suffer from major depressive disorder each year, while in Europe, about 20 million are diagnosed with the major depressive disorder each...

Find More

Digital Therapeutics in Mental Health and Neurological Disorders
Role of Digital Therapeutics (DTx) in Mental Health Management

Over the last decade, various technologies, after being evaluated rigorously, have exhibited competence in treating mental health by becoming an extension of the already present care models. Today, the patient or user can now download a clinical-grade app on the phone, tablet, or computer and use it as a reliable m...

Find More

treatment-resistant-depression-therapeutics-market
How to Cure Treatment-resistant Depression?

Treatment-resistant Depression (TRD) typically refers to inadequate response to at least two antidepressant medications used for a sufficient length of time at an adequate dose with an adequate affirmation of treatment adherence. Treatment-resistant Depression is a relatively common occurrence in clinical practice,...

Find More

mobile-apps-for-mental-health
Plotting the Extensive Demand of Mobile Apps for Mental Health

Mental health services in the new technology-driven world offer so many options. Many of these options are accessible via intuitive apps that are designed to streamline the mental health journey and take most of the guesswork out of finding the expert attention. Most of these apps allow to access the features at an...

Find More

Digital-Therapeutics-for-depression
Evaluating the Role of Digital Therapeutics as an Alternative to Conventional Therapies for Depression

Depression is a mental condition characterized by prolonged series of poor moods, loss of interest and enjoyment in ordinary activities, and low energy, all of which contribute to varying degrees of social and vocational dysfunction. Depression is a chronic condition that affects a person's ability to work, quality...

Find More

major-depressive-disorder-key-companies-emerging-therapies-market-cagr-trends-size-share-growth-forecast
Major Depressive Disorder Market Quadrant Growth Soars Owing to Expected Launch of Key Therapies

Depression is a common and serious medical condition that affects the way people behave, act and think in a negative manner. Also known as Major Depressive Disorder (MDD) or clinical depression, it leads to a persistent feeling of sadness. It affects more than 300 million people of all ages globally and is the lead...

Find More